Please login to the form below

Not currently logged in
Email:
Password:

BMS sales up 14 per cent

Successful launches helped second-quarter sales for Bristol-Myers Squibb sales increase 14 per cent according to the pharmaceutical firm’s financial results

Successful launches helped second-quarter sales for Bristol-Myers Squibb (BMS) sales increase 14 per cent according to the pharmaceutical firm's financial results.

US-based BMS had revenue of $5.43bn for the quarter, compared to $4.77bn for the same period in 2010. This increase in revenue was helped by the launch of skin cancer drug Yervoy (ipilimumab) and Nulojix (belatacept), an immunosupressant to be used following a kidney transplant.

The company also saw sales for Plavix (clopidogrel bisulfate) increase 15 per cent to $1.87bn to remain BMS' best-selling product. The drug, which is co-marketed by Sanofi, was granted an extra six months of marketing exclusivity by the US Food and Drug Adminisration (FDA) in January 2011.

In its financial guidance for the year, the company expects high single-digit revenue growth, as well as extra expense in marketing, sales and administration. Advertising expenses are expected to decrease.

28th July 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Anatomy Health

We are a health information design consultancy focused on developing simple, accessible and inclusive patient communications. From evaluating existing patient...

Latest intelligence

segmentation_pie_thumb.jpg
If you’re not thinking segmentation, you’re not thinking
Having a background in market research I’ve been lucky to work on a number of customer segmentations in my time but working in creative communications it is still too rare...
Improving Outcomes in the Treatment of Opioid Dependence Highlights Report
The 16th annual ‘Improving Outcomes in the Treatment of Opioid Dependence’ (IOTOD)conference took place at the Hilton Madrid Airport hotel on 15–16 May 2018....
Londonvelophobia (fear of cycling in London) – debunked
...

Infographics